Apple (NASDAQ: AAPL) Plans Five New iPhones Including A $2,500 Foldable, Raising Questions About Stock Upside
Apple (NASDAQ: AAPL) is reportedly preparing its most crowded iPhone lineup in years, with at...
Read More
Blue Origin Seeks Outside Investors For The First Time As New Glenn Explosion Clouds IPO Prospects
Jeff Bezos is opening Blue Origin to outside investment for the first time in the rocket...
Read More
Chinese Pastor Ezra Jin Mingri Freed After Trump Personally Raised His Case With Xi Jinping
Pastor Ezra Jin Mingri, leader of one of China’s most prominent underground churches, has...
Read More
Flutter Entertainment (NASDAQ: FLUT), Lululemon (NASDAQ: LULU), And Chevron (NYSE: CVX): Cash Producers Worth Watching And One To Avoid
Strong free cash flow is widely regarded as a hallmark of business quality, but high cash...
Read More
Politics, Finance and Energy News Site Foreign Policy Journal Listed for Sale
Foreign Policy Journal, a longstanding digital news publication covering US and international...
Read More
Netflix (NASDAQ: NFLX) Share Price Slides Over 20% In 2026, But Valuation And Growth Metrics Signal A Buying Opportunity
Netflix (NASDAQ: NFLX) has shed more than 21% of its market value in 2026, rattling investors and...
Read More
Meta Platforms (NASDAQ: META) Eyes Cloud Revenue But Margin Trade-Off Looms For Investors
Meta Platforms (NASDAQ: META) has spent years asking investors to trust its artificial...
Read More
GameStop (NYSE: GME) Renews eBay Pursuit As Ryan Cohen Withdraws Performance Award And Financial Targets Climb
GameStop (NYSE: GME) is pressing ahead with a potential acquisition of eBay despite having already...
Read More
Lockheed Martin (NYSE: LMT), Northrop Grumman (NYSE: NOC), And RTX (NYSE: RTX) Emerge As Top Defense Picks Amid Record Budget Tailwinds
Defense stocks occupy a rare position in today’s market, where geopolitical anxiety, fiscal...
Read More
Johnson & Johnson (NYSE: JNJ) Shuns $100 Billion GLP-1 Race, Positioning Itself As A Stronger Long-Term Bet Than Eli Lilly (NYSE: LLY)
Johnson & Johnson (NYSE: JNJ) is deliberately stepping back from the GLP-1 weight-loss drug...
Read More